Generate a tailored SOP for Dr. Shana Kelley. Improve your application with a focused, well-structured draft.
Shana Kelley’s research focuses on the development of new technologies for disease diagnosis and drug discovery in life sciences. Kelley’s lab combines approaches from materials chemistry, biomolecular chemistry, and engineering to create devices that manipulate and measure biological activities. The lab is dedicated to developing innovative technologies that track biomolecular and cellular analytes, which are critical for diagnosing disease and discovering new therapeutics. Their work includes the creation of ultrasensitive analytical methods that accurately report disease biomarkers from complex clinical specimens, facilitating early detection of diseases. Additionally, the lab is advancing high-throughput analytical tools that detect nucleic acid sequences and protein biomarkers in biological samples with high specificity and sensitivity. During her career, Kelley has developed numerous biotechnologies and has translated these innovations into clinical practice to improve the early detection and diagnosis of diseases, thus enhancing patient care quality. She is known for her work on nanoparticle technologies that detect specific markers on cancer cells and has pioneered methods for targeted drug delivery to mitochondria, which is crucial for research on mitochondrial DNA damage.
Department of Sociology